Israel Englander Vascular Biogenics Ltd. Transaction History

Millennium Management LLC

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 15, 2022	BUY	$1.22 - $1.95 $23,438 - $37,463	19,212 New	19,212 $31,000
Q3 2021 Nov 15, 2021	SELL	$1.94 - $2.55 $72,092 - $94,760	-37,161 Closed	0 $0
Q2 2021 Aug 16, 2021	BUY	$1.69 - $2.67 $62,802 - $99,219	37,161 New	37,161 $89,000
Q1 2021 May 17, 2021	SELL	$1.79 - $2.91 $69,212 - $112,518	-38,666 Closed	0 $0
Q4 2020 Feb 16, 2021	BUY	$1.07 - $2.0 $41,372 - $77,332	38,666 New	38,666 $73,000
Q3 2020 Nov 16, 2020	SELL	$1.11 - $1.4 $257,813 - $325,169	-232,264 Closed	0 $0
Q2 2020 Aug 14, 2020	BUY	$1.12 - $1.63 $246,249 - $358,381	219,866 Added 1773.4%	232,264 $297,000
Q1 2020 May 14, 2020	BUY	$0.96 - $1.57 $11,902 - $19,464	12,398 New	12,398 $17,000
Q4 2017 Feb 14, 2018	SELL	$5.65 - $9.0 $76,642 - $122,085	-13,565 Closed	0 $0
Q3 2017 Nov 14, 2017	BUY	$4.15 - $7.2 $56,294 - $97,668	13,565	13,565 $83,000

416K

Ticker VBLT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 69,348,896
Description
Vascular Biogenics Ltd., a clinical stage biopharmaceutical company, develops therapeutics for the treatment of cancer and immune-inflammatory diseases in Israel and the United States. Its programs are based on its vascular targeting system, a gene-based technology targeting newly formed blood vessels; and monocyte targeting technology, an antib...

Get notified when there are updates to the investment portfolio of Millennium Management LLC, based on Form 13F filings with the SEC.

Stay updated on Millennium Management LLC and Israel Englander with notifications on news.